ImmunoTargets and Therapy
Volume 12, 2023 - Issue
Open access
209
Views
0
CrossRef citations to date
0
Altmetric
LETTER
Dupilumab Treatment is Not Associated with Increased Risk of Overall Skin Infections [Letter]
Simmi Wiggins1 Sanofi, 410 Thames Valley Park Dr, Reading, RG6 1PT, UKCorrespondence[email protected]
& Noah A Levit2 Regeneron Pharmaceuticals Inc, Tarrytown, NY, 10591, USA
Pages 77-78
|
Received 15 May 2023, Accepted 20 May 2023, Published online: 25 May 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.